Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ester
    Member
    • Jun 2008
    • 11

    #1

    PhiX control lane in Hiseq2500

    Hello,

    I would like to know if you are running phiX in a separate lane to calculate a matrix in HiSeq2500 runs.

    And if not, what applications are you running (RNA-Seq, ChIP-seq, exome, etc.) and how are you calculating the matrix for pre/phasing?

    Thanks
    Ester
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Do you have a particular kind of sample that you are worried about? Are you referring to a "normal" run on the HiSeq 2500 or rapid mode? Having just two lanes to work with (in rapid mode) it would be expensive to run phiX on one of the lanes but it should be possible to do and to designate it as the "control" lane.

    With regular flow cell (8 lane) you can either run phiX in one lane (as a control).

    In either case, you can also run a "normal" sample that is expected to have uniform nucleotide distribution and designate that lane as control.
    Last edited by GenoMax; 07-01-2013, 03:49 AM.

    Comment

    • ester
      Member
      • Jun 2008
      • 11

      #3
      Thank you for your answer.

      I was thinking of regular flow cells (8 lanes). We are worried about chIP-seq or even RNA-seq samples with biases in the nucleotide composition.

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        If you want to be absolutely sure then indeed use a control lane but in general you should not need a control lane with regular ChIP-seq and RNA-seq samples.

        You will see some base bias with Illumina sequencing (specially for RNA-seq) in the first 10-15 bases. That is normal. See this thread for background information: http://seqanswers.com/forums/showthread.php?t=11843

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        43 views
        0 reactions
        Last Post SEQadmin2  
        Working...